Download PDF
Thromb Haemost 2019; 119(06): 952-961
DOI: 10.1055/s-0039-1685140
Blood Cells, Inflammation and Infection
Georg Thieme Verlag KG Stuttgart · New York

Reduced Mannose-Binding Lectin-Associated Serine Protease (MASP)-1 is Associated with Disturbed Coagulation in Septic Shock

Julie Brogaard Larsen
1   Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark
,
Mathies Appel Laursen
1   Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark
,
Christine Lodberg Hvas
2   Department of Intensive Care Medicine, Aarhus University Hospital, Aarhus, Denmark
,
Kim Michael Larsen
2   Department of Intensive Care Medicine, Aarhus University Hospital, Aarhus, Denmark
,
Steffen Thiel
3   Department of Biomedicine, Aarhus University, Aarhus, Denmark
,
Anne-Mette Hvas
1   Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark
4   Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
› Author Affiliations Funding This study was supported by grants from Health Aarhus University, the Central Denmark Region Health Research Fund, the A.P. Møller Foundation for Medical Research, King Christian X's Foundation, Frode Nyegaard's Foundation, L.F. Foght's Foundation and Emil and Inger Hertz's Foundation.
Further Information

Publication History

13 December 2018

22 February 2019

Publication Date:
15 April 2019 (online)

    Permissions and Reprints

Abstract

Background Activation of the complement system is part of the dysregulated immune response in sepsis. The mannose-binding lectin-associated serine proteases (MASP)-1 and -2 activate the lectin pathway of the complement system. Besides, these proteins can activate coagulation in vitro. However, the role of the lectin pathway proteins in the development of sepsis-related disseminated intravascular coagulation (DIC) is only sparsely investigated.

Aim This article investigates the association between lectin pathway proteins and coagulation disturbances in septic shock patients.

Materials and Methods We included 36 septic shock patients from the intensive care unit, Aarhus University Hospital, Denmark. Blood samples were obtained within 24 hours after admission (day 1), and subsequently on day 2 and day 3. Plasma concentrations of mannose-binding lectin (MBL), H-ficolin, M-ficolin, CL-L1, CL-K1, MASP-1, -2 and -3, MBL-associated proteins of 19 and 44 kDa as well as complement factor C3dg were assessed. Standard coagulation parameters, thrombin generation, thrombin–anti-thrombin (TAT) complex and pro-thrombin fragment 1 + 2 were measured. Sequential Organ Failure Assessment (SOFA) score, DIC score and 30-day mortality were assessed.

Results Reduced MASP-1 plasma concentration was associated with DIC score ≥5 (p = 0.02), impaired thrombin generation (p = 0.03) and lower plasma TAT complex levels (p = 0.03). No association was found between lectin pathway proteins and SOFA score or 30-day mortality.

Conclusion Reduced MASP-1 concentrations were associated with impaired coagulation in septic shock patients. This indicates that increased MASP-1 activation and consumption is associated with the more severe coagulation disturbances in sepsis and points to a possible role for MASP-1 in sepsis-related DIC.

Keywords

sepsis - disseminated intravascular coagulation - complement pathway, mannose-binding lectin - mannose-binding protein-associated serine proteases

Authors' Contributions

J.B.L., C.L.H., K.M.L., S.T. and A.M.H. contributed to design and study planning. J.B.L. and M.A.L. performed patient inclusion, blood sampling and data collection. J.B.L. analysed lectin pathway proteins, performed statistical analyses and prepared the first draft of the manuscript. All authors contributed to critical revision of the manuscript.


Supplementary Material

 

  • References

  • 1 Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29 (07) 1303-1310
    CrossrefPubMedGoogle Scholar
  • 2 Vincent JL, Marshall JC, Namendys-Silva SA. , et al; ICON investigators. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med 2014; 2 (05) 380-386
    CrossrefPubMedGoogle Scholar
  • 3 Kienast J, Juers M, Wiedermann CJ. , et al; KyberSept investigators. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 2006; 4 (01) 90-97
    PubMedGoogle Scholar
  • 4 Dhainaut JF, Yan SB, Joyce DE. , et al. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2004; 2 (11) 1924-1933
    CrossrefPubMedGoogle Scholar
  • 5 Gando S, Saitoh D, Ogura H. , et al; Japanese Association for Acute Medicine Sepsis Registry Study Group. A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit Care 2013; 17 (03) R111
    CrossrefPubMedGoogle Scholar
  • 6 Levi M, Sivapalaratnam S. Disseminated intravascular coagulation: an update on pathogenesis and diagnosis. Expert Rev Hematol 2018; 11 (08) 663-672
    CrossrefPubMedGoogle Scholar
  • 7 Ekdahl KN, Teramura Y, Hamad OA. , et al. Dangerous liaisons: complement, coagulation, and kallikrein/kinin cross-talk act as a linchpin in the events leading to thromboinflammation. Immunol Rev 2016; 274 (01) 245-269
    CrossrefPubMedGoogle Scholar
  • 8 Conway EM. Complement-coagulation connections. Blood Coagul Fibrinolysis 2018; 29 (03) 243-251
    CrossrefPubMedGoogle Scholar
  • 9 Degn SE, Thiel S, Jensenius JC. New perspectives on mannan-binding lectin-mediated complement activation. Immunobiology 2007; 212 (4-5): 301-311
    CrossrefPubMedGoogle Scholar
  • 10 Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000; 68 (02) 688-693
    CrossrefPubMedGoogle Scholar
  • 11 Aoyagi Y, Adderson EE, Min JG. , et al. Role of L-ficolin/mannose-binding lectin-associated serine protease complexes in the opsonophagocytosis of type III group B streptococci. J Immunol 2005; 174 (01) 418-425
    CrossrefPubMedGoogle Scholar
  • 12 Ali YM, Lynch NJ, Haleem KS. , et al. The lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infection. PLoS Pathog 2012; 8 (07) e1002793
    CrossrefPubMedGoogle Scholar
  • 13 Ng PM, Le Saux A, Lee CM. , et al. C-reactive protein collaborates with plasma lectins to boost immune response against bacteria. EMBO J 2007; 26 (14) 3431-3440
    CrossrefPubMedGoogle Scholar
  • 14 Charchaflieh J, Rushbrook J, Worah S, Zhang M. Activated complement factors as disease markers for sepsis. Dis Markers 2015; 2015: 382463
    PubMedGoogle Scholar
  • 15 Hess K, Ajjan R, Phoenix F, Dobó J, Gál P, Schroeder V. Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation. PLoS One 2012; 7 (04) e35690
    CrossrefPubMedGoogle Scholar
  • 16 Krarup A, Wallis R, Presanis JS, Gál P, Sim RB. Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. PLoS One 2007; 2 (07) e623
    CrossrefPubMedGoogle Scholar
  • 17 Krarup A, Gulla KC, Gál P, Hajela K, Sim RB. The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen. Biochim Biophys Acta 2008; 1784 (09) 1294-1300
    CrossrefPubMedGoogle Scholar
  • 18 Jenny L, Dobó J, Gál P, Pál G, Lam WA, Schroeder V. MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model. PLoS One 2018; 13 (01) e0191292
    CrossrefPubMedGoogle Scholar
  • 19 La Bonte LR, Pavlov VI, Tan YS. , et al. Mannose-binding lectin-associated serine protease-1 is a significant contributor to coagulation in a murine model of occlusive thrombosis. J Immunol 2012; 188 (02) 885-891
    CrossrefPubMedGoogle Scholar
  • 20 Takahashi K, Chang WC, Takahashi M. , et al. Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation. Immunobiology 2011; 216 (1-2): 96-102
    CrossrefPubMedGoogle Scholar
  • 21 Larsen JB, Hvas CL, Hvas AM. The lectin pathway in thrombotic conditions-a systematic review. Thromb Haemost 2018; 118 (07) 1141-1166
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Sprong T, Mollnes TE, Neeleman C. , et al. Mannose-binding lectin is a critical factor in systemic complement activation during meningococcal septic shock. Clin Infect Dis 2009; 49 (09) 1380-1386
    CrossrefPubMedGoogle Scholar
  • 23 Zhao X, Chen YX, Li CS. Predictive value of the complement system for sepsis-induced disseminated intravascular coagulation in septic patients in emergency department. J Crit Care 2015; 30 (02) 290-295
    CrossrefPubMedGoogle Scholar
  • 24 Takahashi K, Ohtani K, Larvie M. , et al. Elevated plasma CL-K1 level is associated with a risk of developing disseminated intravascular coagulation (DIC). J Thromb Thrombolysis 2014; 38 (03) 331-338
    CrossrefPubMedGoogle Scholar
  • 25 Singer M, Deutschman CS, Seymour CW. , et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315 (08) 801-810
    CrossrefPubMedGoogle Scholar
  • 26 Moreno RP, Metnitz PG, Almeida E. , et al; SAPS 3 Investigators. SAPS 3--from evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 2005; 31 (10) 1345-1355
    CrossrefPubMedGoogle Scholar
  • 27 Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47 (01) 207-214
    CrossrefPubMedGoogle Scholar
  • 28 Wittenborn T, Thiel S, Jensen L, Nielsen HJ, Jensenius JC. Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma. J Innate Immun 2010; 2 (02) 167-180
    CrossrefPubMedGoogle Scholar
  • 29 Degn SE, Jensen L, Gál P. , et al. Biological variations of MASP-3 and MAp44, two splice products of the MASP1 gene involved in regulation of the complement system. J Immunol Methods 2010; 361 (1-2): 37-50
    CrossrefPubMedGoogle Scholar
  • 30 Degn SE, Thiel S, Nielsen O, Hansen AG, Steffensen R, Jensenius JC. MAp19, the alternative splice product of the MASP2 gene. J Immunol Methods 2011; 373 (1-2): 89-101
    CrossrefPubMedGoogle Scholar
  • 31 Thiel S, Møller-Kristensen M, Jensen L, Jensenius JC. Assays for the functional activity of the mannan-binding lectin pathway of complement activation. Immunobiology 2002; 205 (4-5): 446-454
    CrossrefPubMedGoogle Scholar
  • 32 Axelgaard E, Jensen L, Dyrlund TF. , et al. Investigations on collectin liver 1. J Biol Chem 2013; 288 (32) 23407-23420
    CrossrefPubMedGoogle Scholar
  • 33 Møller-Kristensen M, Jensenius JC, Jensen L. , et al. Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals. J Immunol Methods 2003; 282 (1-2): 159-167
    CrossrefPubMedGoogle Scholar
  • 34 Troldborg A, Jensen L, Deleuran B, Stengaard-Pedersen K, Thiel S, Jensenius JC. The C3dg fragment of complement is superior to conventional C3 as a diagnostic biomarker in systemic lupus erythematosus. Front Immunol 2018; 9: 581
    CrossrefPubMedGoogle Scholar
  • 35 Troldborg A, Hansen A, Hansen SW, Jensenius JC, Stengaard-Pedersen K, Thiel S. Lectin complement pathway proteins in healthy individuals. Clin Exp Immunol 2017; 188 (01) 138-147
    CrossrefPubMedGoogle Scholar
  • 36 Krarup A, Sørensen UB, Matsushita M, Jensenius JC, Thiel S. Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun 2005; 73 (02) 1052-1060
    CrossrefPubMedGoogle Scholar
  • 37 Hein E, Honoré C, Skjoedt MO, Munthe-Fog L, Hummelshøj T, Garred P. Functional analysis of Ficolin-3 mediated complement activation. PLoS One 2010; 5 (11) e15443
    CrossrefPubMedGoogle Scholar
  • 38 Taylor Jr FB, Toh CH, Hoots WK, Wada H, Levi M. ; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86 (05) 1327-1330
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (02) 377-381
    CrossrefPubMedGoogle Scholar
  • 40 Jenny L, Dobó J, Gál P, Schroeder V. MASP-1 induced clotting--the first model of prothrombin activation by MASP-1. PLoS One 2015; 10 (12) e0144633
    CrossrefPubMedGoogle Scholar
  • 41 Jenny L, Dobó J, Gál P, Schroeder V. MASP-1 of the complement system promotes clotting via prothrombin activation. Mol Immunol 2015; 65 (02) 398-405
    CrossrefPubMedGoogle Scholar
  • 42 Toh CH, Samis J, Downey C. , et al. Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca(++)-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation. Blood 2002; 100 (07) 2522-2529
    CrossrefPubMedGoogle Scholar
  • 43 Tripodi A. Thrombin generation assay and its application in the clinical laboratory. Clin Chem 2016; 62 (05) 699-707
    CrossrefPubMedGoogle Scholar
  • 44 Gando S, Levi M, Toh CH. Disseminated intravascular coagulation. Nat Rev Dis Primers 2016; 2: 16037
    CrossrefPubMedGoogle Scholar
  • 45 Dobó J, Harmat V, Beinrohr L, Sebestyén E, Závodszky P, Gál P. MASP-1, a promiscuous complement protease: structure of its catalytic region reveals the basis of its broad specificity. J Immunol 2009; 183 (02) 1207-1214
    CrossrefPubMedGoogle Scholar
  • 46 Paréj K, Dobó J, Závodszky P, Gál P. The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while α2-macroglobulin is not. Mol Immunol 2013; 54 (3-4): 415-422
    CrossrefPubMedGoogle Scholar
  • 47 Megyeri M, Jani PK, Kajdácsi E. , et al. Serum MASP-1 in complex with MBL activates endothelial cells. Mol Immunol 2014; 59 (01) 39-45
    CrossrefPubMedGoogle Scholar
  • 48 Chen J, Chung DW. Inflammation, von Willebrand factor, and ADAMTS13. Blood 2018; 132 (02) 141-147
    CrossrefPubMedGoogle Scholar